Suchergebnisse - "Corre, Romain"

PubPharm (78)

1

Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study)

enthalten in: Targeted oncology | 2023

von Dhamelincourt, E. | Descourt, R. | Rousseau-Bussac, G. | +15

2

Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study)

enthalten in: Targeted oncology | 2023

von Dhamelincourt, E. | Descourt, R. | Rousseau-Bussac, G. | +15

3

Real-World Treatment Outcomes of MET Exon14 Skipping in Non-small Cell Lung Cancer : GFPC 03-18 Study

enthalten in: Targeted oncology | 2023

von Babey, H. | Jamme, P. | Curcio, H. | +12

4

Real-World Treatment Outcomes of MET Exon14 Skipping in Non-small Cell Lung Cancer: GFPC 03-18 Study

enthalten in: Targeted oncology | 2023

von Babey, H. | Jamme, P. | Curcio, H. | +12

5

Real-World Treatment Outcomes of MET Exon14 Skipping in Non-small Cell Lung Cancer: GFPC 03-18 Study

enthalten in: Targeted oncology | 2023

von Babey, H. | Jamme, P. | Curcio, H. | +12

6

Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic non-small-cell lung cancer : A secondary analysis of ESOGIA-GFPC-GECP 08-02 study

enthalten in: Journal of geriatric oncology | 2023

von Gendarme, S. | Zebachi, S. | Corre, R. | +12

7

Safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer : An open-label phase II trial (VinMetAtezo)

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2023

von Vergnenegre, A. | Monnet, I. | Ricordel, C. | +13

8

Reaching multidisciplinary consensus on the management of non-bulky/non-infiltrative stage IIIA N2 non-small cell lung cancer

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2023

von Scherpereel, A. | Martin, E. | Brouchet, L. | +7

9

Pembrolizumab plus pemetrexed-carboplatin combination in first-line treatment of advanced non-squamous non-small cell lung cancer : a multicenter real-life study (CAP29)

enthalten in: Translational lung cancer research | 2023

von Renaud, E. | Ricordel, C. | Corre, R. | +11

10

Real-life second-line epirubicin-paclitaxel regimen as treatment of relapsed small-cell lung cancer : EpiTax study

enthalten in: Cancer medicine | 2023

von Annic, J. | Babey, H. | Corre, R. | +11

1
2
3
4
5
6
7
8
Nächster »
[8]